Life sciences organizations face a security paradox: attack surfaces are expanding faster than security teams can scale. From connected medical devices and clinical trial systems to global supply chains and AI-driven drug discovery platforms, the threat landscape has never been more complex or more consequential.
Shift Zero reimagines how security operations work. Rather than chasing alerts and managing vulnerability backlogs by hand, leading life sciences organizations are moving toward autonomous detection, prioritization, and response. The result is shorter time to remediate, less noise, and security teams free to focus on what matters most.
In this session, we’ll explore how security leaders in pharma, med device, and CRO environments are:
Whether you’re modernizing a legacy SecOps program or building toward a fully autonomous security posture, this session will give you a practical roadmap for what Shift Zero looks like in a regulated, high-stakes industry.
Please complete the form below to register to this event. All fields are required.
Please fix the following errors:
For more information on how your personal data will be processed, see our Privacy Statement and Terms and Conditions.
, , , United States